Haomeng Zhang

No ORCID on file · 4 papers in corpus
review 2025
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1702273

Ovarian cancer, particularly epithelial ovarian cancer (EOC), is the most aggressive and lethal gynecologic malignancy, necessitating the development of innovative and potent therapies to improve its prognosis. Human polo-like kinase 1 (PLK…

lab-animal 2025
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1520771

OBJECTIVE: Chronic inflammation is a key contributor to carcinogenesis, progression, and chemoresistance in ovarian cancer, making inflammatory pathways a logical therapeutic target for the treatment of this disease. Sulindac, a commonly us…

case-report 2024
Clinical case reports ·doi:10.1002/ccr3.8716

We present a rare case of a female pelvic solitary fibrous tumor unsuccessfully resected using single-port laparoscopy, requiring conversion to laparotomy. Although the resection was successful, the surgical approach could have been improve…

review 2023
·doi:10.1016/j.jeud.2023.100049

Endometriosis is an estrogen-dependent chronic inflammatory disease. The pathogenesis of endometriosis is affected by numerous factors including immune, endocrine, genetic, and environmental influences. The relative and absolute levels of v…